MedPath

Legume Diet Satiety Pilot Study

Not Applicable
Completed
Conditions
Colorectal Carcinoma
Obesity
Interventions
Behavioral: Legume diet group
Behavioral: Control diet group
Device: Smartpill
Other: legumes
Registration Number
NCT02269631
Lead Sponsor
Emory University
Brief Summary

This pilot study is designed to test the effects of a high legume (dried bean) diet on hunger and other indicators of health over the course of eight weeks, compared to a more conventional healthy diet.

Detailed Description

The goal of the currently proposed study is to conduct a randomized controlled feeding pilot study within a more diverse population also at high risk for colorectal carcinoma (CRC) to evaluate whether a high-legume diet will result in increased satiety and in turn will facilitate reduced energy intake and weight loss compared to a control diet provided under similar conditions. In addition, explore potential beneficial effects of the high-legume diet on gastric emptying and circulating levels of appetite-regulating hormones and other biomarkers. Dietary behaviors that are even moderately more satiating over time have the potential to enhance weight loss and could lead to a significant public health impact among populations at high risk for colorectal carcinoma (CRC) and other chronic diseases.

Towards the end of the study, the participants will do an additional test, looking at how long food takes to pass through the digestive system using a SmartPill capsule. The SmartPill is a pill about the size of a large multivitamin that can measure pH, pressure, and temperature changes, which it uses to assess where in the digestive tract it is. The participant swallows the pill, and carries around a receiver that is about the size of a deck of cards for the next 3-5 days. The SmartPill is expelled, and the receiver notifies the participant that they can return the receiver to the study personnel.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
12
Inclusion Criteria
  • BMI overweight-obese: 25.0-40 kg/m2
  • Colonoscopy within the last two years that found ≥1 adenoma
  • English speaking
  • Ambulatory, able to come to either food distribution site to pick up food and participate in clinical examinations and laboratory tests
Read More
Exclusion Criteria
  • Serious medical condition (e.g., cancer, heart disease, kidney disease, diabetes)
  • History of CRC, bowel resection, polyposis syndrome, or inflammatory bowel disease
  • Smoked regularly in the past year
  • Dietary restrictions substantially limiting compliance or vegetarian or Vegan diet
  • Planning on changing diet or exercise behavior in the next 6 months
  • Regular use of medication that may alter inflammation markers, insulin, glucose, or gut function (i.e. regular use of non-steroidal anti-inflammatory medication, insulin therapy, steroid therapy, or antibiotics)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Legume diet groupLegume diet groupMeals will include approximately 1 ½ cups of cooked legumes, such as pinto, baked and navy beans as part of your 2 daily main dishes (lunch and dinner) and additional foods and snacks, preferably from the recommended healthy foods list. The smartpill will be administered at the end of the study.
Legume diet groupSmartpillMeals will include approximately 1 ½ cups of cooked legumes, such as pinto, baked and navy beans as part of your 2 daily main dishes (lunch and dinner) and additional foods and snacks, preferably from the recommended healthy foods list. The smartpill will be administered at the end of the study.
Legume diet grouplegumesMeals will include approximately 1 ½ cups of cooked legumes, such as pinto, baked and navy beans as part of your 2 daily main dishes (lunch and dinner) and additional foods and snacks, preferably from the recommended healthy foods list. The smartpill will be administered at the end of the study.
Control diet groupControl diet groupMeals will be healthy, typical American foods (without legumes) for 2 daily main dishes and additional foods and snacks, preferably from the recommended healthy foods list.The smartpill will be administered at the end of the study.
Control diet groupSmartpillMeals will be healthy, typical American foods (without legumes) for 2 daily main dishes and additional foods and snacks, preferably from the recommended healthy foods list.The smartpill will be administered at the end of the study.
Primary Outcome Measures
NameTimeMethod
Change in WeightBaseline to 8 weeks

Evaluate the effects of a high-legume diet compared to a control diet with a similar macronutrient profile on weight change in a randomized controlled feeding study.

Secondary Outcome Measures
NameTimeMethod
SatietyTime course response at baseline and 8 weeks

Use self-reported satiety questionnaire to compare short-term responses to test meals.

Gastric Emptying Time8 weeks

Compare the effects of the high-legume and control diets on gastric emptying time

Change in Plasma Insulin Level (Biomarker of Appetite Regulation)Baseline to 8 weeks

Compare the effects of the high-legume and control diets on plasma insulin level in a meal response time (30 min) course experiment.

Energy IntakeBaseline to 8 weeks

Compare the effects of the high-legume and control diets on self-reported dietary intake measured by telephone 24-hour dietary recalls.

Trial Locations

Locations (2)

Morehouse

🇺🇸

Atlanta, Georgia, United States

Emory ACTSI

🇺🇸

Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath